Results of the Long-Term Outcomes Study of Ibogaine Treatment in Mexico - Thomas Kingsley Brown

Ibogaine treatment in Mexico is presented through preliminary results of an observational study focused on opiate addiction. The research tracked thirty participants for one year following treatment, utilizing the Addiction Severity Index Lite to measure multi-dimensional life improvements and the Subjective Opioid Withdrawal Scale to assess acute detoxification. The findings indicate no severe adverse medical events related to the substance. While a significant decline in withdrawal symptoms and drug cravings was observed across the cohort, high relapse rates were reported during the first six months, highlighting a critical need for sustained integration support. The study underscores how Ibogaine facilitates a window of abstinence, yet long-term recovery depends heavily on post-treatment care and social support structures.